At Sensient Technologies, one of the world’s largest dyemakers, scientists are working hard to find natural alternatives.

The drug, called medetomidine, is used by veterinarians to sedate pets. It’s similar to xylazine, another animal drug that has already made the US opioid crisis worse, The Associated Press reported.

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

Nipocalimab-aahu is a human immunoglobulin G1 monoclonal antibody that binds with high affinity to the neonatal Fc receptor, resulting in the reduction of circulating IgG levels.

The FDA is expected to decide on treatments for bullous pemphigoid, hereditary angioedema, HIV PrEP, ovarian cancer, and RSV.

Increase seen in lifetime use among adults and adolescents; past-year use higher among young adults, older adults.